- CONAPI updated its recommendations on the use of heterologous vaccine schedules against COVID-19:
Preferably, the vaccination schedule should be completed using the same product keeping the recommended administration interval.
If there are insufficient vaccines in country to complete the primary schedule with the same vaccine, one can complete the primary schedule with another vaccine of the same platform or from a different platform.
For people who received a primary schedule of vaccines not used in Guatemala and have URL authorization from WHO, one can complete the primary schedule with another vaccine from the same platform or from a different platform.
Information should be provided to the recipient about the possibility of increased mild adverse reactions, for which the care and surveillance guidelines for ESAVIs must be followed.
The implementation of a heterologous schedule must be accompanied by a clear information campaign on the safety and effectiveness of the use of combinations of vaccines against COVID-19 by MoH.